Complex Molecule Disorders Flashcards

1
Q

What are the 2 most common peroxisomal disorders?

A

Zellweger spectrum and X-ALD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mutations in what genes cause Zellweger spectrum disorder?

A

PEX1*, PEX6, PEX12, PEX26

*most common

  • No common variants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the reason/mechanism behind the development of Zellweger?

A

Individuals cannot make the peroxisome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the age of presentation of Zellweger?

A

Severe: Neonatal
Mild: Childhood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What body systems are the most affected by Zellweger?

A

Neurologic, liver, skeletal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a key radiographic feature of Zellweger?

A

Stippling of bone (knee cap example)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What biochemical testing is done for Zellweger? Treatment?

A

Very long chain fatty acids

No treatment, just symptomatic support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True or false: X-ALD is on NBS

A

True

on RUSP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the reason/mechanism behind the development of X-ALD?

A

No transporter into the peroxisome for VLCFA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mutations in what gene cause X-ALD? What is the mode of inheritance?

A

ABCD1; X-Linked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What percentage of X-ALD cases are de novo?

A

4%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 2 types of presentation for X-ALD? Is there any genotype-phenotype correlation for which one someone will develop?

A
  1. Childhood cerebral onset
  2. Adult-onset adrenomyeloneuropathy (AMN)

No; we’re never able to know which one will develop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the demographics/features of childhood cerebral onset of X-ALD?

A

Adrenoleukodystrophy
4-8 years old
Neurological regression
Males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the demographics/features of adrenomyeloneuropathy onset of X-ALD?

A

Adrenoleukodystrophy
20-40 years old
Progressive leg stiffness
Bowel/bladder dysfunction
Males & some females

“Issues with everything ‘South of the Border’”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the workup and treatment for X-ALD?

A

Very Long Chain Fatty Acids

Stem cell transplant (mostly reserved for severe/childhood cerebral cases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are sphingolipidoses disorders?

A

Conditions where your body cannot break down sphingolipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What 3 sphingolipidoses do NOT have neurological involvement?

A

Gaucher, Fabry, and Pompe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mutations in what gene cause Gaucher Type 1?

A

GBA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Where can buildup occur in Gaucher Type 1? What are the symptoms?

A

Bone, liver, spleen

Bone pain, bone marrow infiltration, anemia, thrombocytopenia, hepatosplenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the typical age of presentation of Gaucher T1?

A

Late childhood - young adulthood

Age of diagnosis/onset depends on how quickly buildup is happening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the carrier frequency of Gaucher T1 in AJ population?

A

1 in 15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the biochemical testing workup for Gaucher T1? Treatment?

A

Workup: Lyso-Gb1, enzyme
Treatment: ERT, Substrate reduction (pills)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Mutations in which gene cause Fabry disease? What is the mode of inheritance?

A

GLA; X-Linked (females are affected)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the typical age of presentation for Fabry?

A

Boys: childhood
Females: adulthood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are most common symptoms of Fabry?

A

Neuropathic pain:
- hands and feet
- tingling and prickling
- burning

Decreased sweating

GI:
- cramps
- constipation
- diarrhea

Angiokeratomas:
- lower abdomen
- bathing trunk

W/O treatment:
- kidney disease
- abnormal heart rhythms
- heart enlargement
- increased stroke risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the biochemical workup and treatment for Fabry?

A

Workup: GL3, enzyme, (females: genetic testing only)
Treatment: ERT, substrate reduction (pills)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Mutations in what gene cause Pompe Disease? What is the mechanism?

A

GAA

Repeat disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How much enzyme is present in infantile-form Pompe disease? Late-onset (juvenile or adult-onset)?

A

Infantile: little or no enzyme
Late-onset: reduced enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

When is typical onset for infantile and late onset Pompe disease?

A

Infantile: first few months of life
Late-onset: any age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are signs of infantile-form Pompe disease?

A

Hypertrophic cardiomyopathy (HCM) (enlarged heart), skeletal muscle weakness (diaphragm & other breathing muscles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are signs of late-onset Pompe disease?

A

Proximal limb weakness (shoulders & hips), progressive diaphragm weakness (breathing difficulties)
heart not involved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is the late-onset Pompe disease compound heterozygote state variant?

A

GAA c.336-13T>G

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is the biochemical workup and treatment for Pompe Disease?

A

Workup: Urine Hex4, enzyme
Treatment: ERT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

True or false: Individuals with Pompe Disease do NOT have normal cognition

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Mutations in what genes cause Niemann Pick C?

A

NPC1
NPC2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What symptoms do almost all individuals affected by Niemann Pick C have?

A

Progressive neurologic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What signs are seen in early infantile onset Niemann Pick C?

A

Delay in developmental milestones, developmental regression

38
Q

What signs are seen in infantile & childhood onset Niemann Pick C? (around 6 years old)

A

Slurred speech, learning difficulties, unsteady gait, clumsiness, seizures or cataplexy (a sudden and brief episode of muscle weakness that typically occurs in response to strong emotions, such as laughter, excitement, surprise, or anger)

39
Q

What signs are seen in teenage & adult onset Niemann Pick C?

A

Psychiatric symptoms
Progressive cognitive impairment

40
Q

What is the biochemical workup and treatment for Niemann Pick C?

A

Workup: Oxysterols
Treatment: Miglustat

41
Q

What is average age of onset for Krabbe and Tay-Sachs/Sandhoff/GM2?

A

5-6 months of age

42
Q

What is the average age of onset of neuronal ceroid lipofuscinosis?

A

1-2 years old

43
Q

What is the average age of onset of metachromatic leukodystrophy?

A

2+ years old

44
Q

Mutations in what gene cause Krabbe?

45
Q

Mutations in which genes cause Tay-Sachs/Sandhoff/GMS Gangliosides?

A

HexA, HexB

46
Q

Mutations in which genes cause neuronal ceroid lipofuscinosis?

A

CLN1, CLN2, CLN3, CLN4, CLN5…

47
Q

Mutations in which gene cause metachromatic leukodystrophy?

48
Q

What symptoms are seen in infantile and childhood onset forms of neurological sphingolipidoses?

A

Neurological deterioration
Loss of all skills
Blindness

49
Q

What symptoms are seen in adult/late onset forms of neurological sphingolipidoses?

A

Motor difficulties
Psychiatric symptoms

50
Q

What is a key symptoms of Tay-Sachs compared to the other sphingolipdoses?

A

“Cherry red spot” in the eye

51
Q

What is the biochemical workup in Krabbe?

A

Psychosine

52
Q

What is the biochemical workup in GM2?

A

Urine oligosaccharides

53
Q

What is the biochemical workup in NCL?

A

None - DNA testing

54
Q

What is the biochemical workup in MLD?

A

Urine sulfatides

55
Q

What is the biochemical workup for all sphingolipidoses except for NCL?

A

Enzyme levels

56
Q

What is treatment for Krabbe and MLD?

A

Stem cell transplant

57
Q

What does disease progression typically look like in complex molecule disorders?

A

Normal at birth, progressive disease

58
Q

When is the typical diagnosis age of MPS?

A

Young childhood

59
Q

What are the skeletal findings of MPS?

A

Dysostosis multiplex (abnormalities on x-ray)
Joint contractures

60
Q

What are the nervous system findings in MPS?

A

Progressive neurological deterioration in MPSI severe, MPSII, MPSIII
Carpal tunnel

61
Q

What are the eyes/ears findings in MPS?

A

Optic atrophy
Retinal detachment
Hearing loss

62
Q

What are the face & neck findings in MPS?

A

Coarsening of facial features
Airway narrowing (high risk for anesthesia)

63
Q

What are the other organ findings in MPS?

A

Heart (valves and muscle)
Liver and spleen enlargement

64
Q

What is the gene for MPSI (Severe and attenuated)? What is the genotype-phenotype correlation for each?

A

IDUA

Severe: p.Gln70Ter or p.Trp402Ter
Mild: Missense variants

65
Q

What feature is special to MPSI Severe (Hurler) and Attenuated (Scheie)?

A

Corneal clouding

66
Q

What feature is special to MPSI Scheie?

A

Normal cognition

67
Q

What is the gene for MPSII (Hunter)? Mode of inheritance?

A

IDS; X-Linked

68
Q

What feature is special to MPSII (Hunter)?

A

Significant behavioral concerns (late)

69
Q

What are the genes for MPSIII (Sanfilippo)?

A

SGSH, NAGLU, HGSNAT, GNS

70
Q

What feature is special to MPSIII (Sanfilippo)?

A

Significant behavioral concerns early)

71
Q

What are the genes for MPS IV (Morquio)?

A

GALNS, GLB1

72
Q

What feature is special to MPSIV (Morquio)?

A

Significant skeletal concerns, normal cognition

73
Q

What is the biochemical workup for MPS? Treatments?

A

Workup: Urine glycosaminoglycans (AKA urine mucopolysaccharides), enzyme levels

Treatments: ERT (none for MPSIII)
MPSI: stem cell transplant

74
Q

What is the most common Congenital Disorder of Glycosylation (CDG)?

75
Q

What genes are related to other less common CDGs?

A

MPI, ALG6, ALG3, ALG12, DPM1, MPDU1

76
Q

What are the neurological implications of PMM2-CDG?

A

Cognitive disability
Epilepsies
Stroke

77
Q

What are the organ formation implications of PMM2-CDG?

A

Distinctive facial features
Abnormal fat distribution, inverted nipples
Renal cysts
Brain malformations

78
Q

What are the organ function implications of PMM2-CDG?

A

Immune dysfunction
Coagulopathy (bleeding/clotting)
Hormones (i.e hypothyroid)
Liver dysfunction

79
Q

What is the biochemical workup and treatment for PMM2-CDG?

A

Workup: N-Glycan profile, O-Glycan profile “carbohydrate deficient transferrin”

Treatment: symptomatic
Rarely: specific sugars

80
Q

What condition is a cholesterol synthesis disorder?

A

Smith-Lemli-Opitz

81
Q

What conditions are cholesterol breakdown disorders?

A

FH, Lysosomal acid lipase, cerebrotendinous xanthomastosis

82
Q

What are features of Smith-Lemli-Opitz? Age of presentation?

A

Growth restriction
Cognitive disability
Distinctive features
2-3 toe syndactyly
Cardiac defects
Underdeveloped male genitalia

Infants

83
Q

What is the gene for Smith-Lemli-Opitz?

84
Q

What is the biochemical workup and treatment for Smith-Lemli-Opitz?

A

Workup: 7-Dehydrocholestrol
Treatment: Symptomatic, ?cholesterol

85
Q

What are features of FH? Age of presentation?

A

Xanthelasma
Tendon xanthomas
Corneal arcus
Severely elevated LDL (>190 mg/dL) leading to MI

Adults

86
Q

What genes are associated with FH?

A

LDLR, APOB, PSCK9

87
Q

What is the biochemical workup and treatment for FH?

A

Workup: Lipid panel (HDL, LDL, triglycerides)

Treatment: statins/cholesterol-lowering medications

88
Q

What gene is associated with Lysosomal acid lipase (LAL)?

89
Q

What features do we see in LAL?

A

Atherosclerosis, heart attack, stroke, liver damage/cirrhosis

90
Q

What is the biochemical workup and treatment for LAL?

A

Workup: lipid panel, enzyme levels

Treatment: ERT

91
Q

What gene is associated with cerebrotendinous xanthomastosis?